SECsense Logo

Dexcom, Inc. 8-K Filing Insights: Key Updates for Investors on January 13, 2025

$DXCM
Form 8-K
Filed on: 2025-01-13
Source
Dexcom, Inc. 8-K Filing Insights: Key Updates for Investors on January 13, 2025

Based on the provided section of the financial report, here are the key insights extracted:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • CIK Number: 0001093557
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key: 000-51222
  • IRS Employer Identification Number: 33-0857544
  • Company Address: 6340 Sequence Drive, San Diego, CA 92121
  • Contact Number: 858-200-0200
  1. Filing Details:
  • Filing Type: Form 8-K
  • Filing Date: January 13, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share
  • Stock Ticker Symbol: DXCM
  • Exchange: NASDAQ
  1. Reporting Context:
  • Period Covered: The report pertains to a single day, January 13, 2025.

Summary:

Dexcom, Inc. filed an 8-K report on January 13, 2025, detailing significant information relevant to investors and stakeholders. The company is incorporated in Delaware, trades on NASDAQ under the ticker DXCM, and has a minimal par value for its common stock of $0.001. The filing indicates critical disclosures that may impact investor sentiment or regulatory compliance.

This information is essential for stakeholders to assess the company's current standing and any material events that may influence its operations or market perception on the specified date.